🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Establishment of safety profile of HuMax-CD38 when given as monotherapy in ...
Status
Completed
Location
Multiple Locations
Start Date
2008-03-26
Trial ID
NCT00574288
Treatments Being Tested
Primary Objectives: * VCDI cohort: * To determine the maximum tolerated...
Status
Completed
Location
Investigational Site Number : 250002
Start Date
2015-09-30
Trial ID
NCT02513186
Treatments Being Tested
Multiple myeloma is a type of blood cancer that can come back even after ef...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-09
Trial ID
NCT07740486
Treatments Being Tested
This study is researching a drug called linvoseltamab (also called "study d...
Status
Recruiting
Location
Emory Winship Cancer Institute
Start Date
2026-01-02
Trial ID
NCT07222761
Treatments Being Tested
Multiple myeloma (MM) is a plasma cell disease characterized by the growth ...
Status
Active Not Recruiting
Location
Stanford University School of Med /ID# 242809
Start Date
2022-05-17
Trial ID
NCT05308654
Treatments Being Tested
The main purpose of this study is to assess the safety of the combination o...
Status
Completed
Location
ZNA Stuivenberg
Start Date
2017-11-16
Trial ID
NCT03357952
Treatments Being Tested
Multiple myeloma (MM) is a cancer of the blood's plasma cells. The cancer i...
Status
Recruiting
Location
City of Hope National Medical Center /ID# 273132
Start Date
2025-06-30
Trial ID
NCT06892522
This is a phase 1/2, open label, single-center study designed to assess the...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2022-10-20
Trial ID
NCT05581875
Treatments Being Tested
The purpose of this study is to assess the safety, tolerability, and effica...
Status
Recruiting
Location
University of Alabama At Birmingham Hospital
Start Date
2021-09-16
Trial ID
NCT04973605
Treatments Being Tested
This is a phase 1/2, open label, study designed to assess the safety and cl...
Status
Unknown
Location
Department of Clinical Therapeutics, School of Medicine, National Kapodistrian University of Athens (NKUA)
Start Date
2022-04-13
Trial ID
NCT05280275
Treatments Being Tested